In heterogeneous catalysis, the catalyst is in a different phase from the reactants. Product Details of 1532-97-4, At least one of the reactants interacts with the solid surface in a physical process called adsorption in such a way. 1532-97-4, name is 4-Bromoisoquinoline. In an article，Which mentioned a new discovery about 1532-97-4
Novel pyridyl substituted 4,5-dihydro-[1,2,4]triazolo[4,3-a ]quinolines as potent and selective aldosterone synthase inhibitors with improved in vitro metabolic stability
CYP11B2 inhibition is a promising treatment for diseases caused by excessive aldosterone. To improve the metabolic stability in human liver miscrosomes of previously reported CYP11B2 inhibitors, modifications were performed via a combination of ligand-and structure-based drug design approaches, leading to pyridyl 4,5-dihydro-[1,2,4]triazolo[4,3-a]quinolones. Compound 26 not only exhibited a much longer half-life (t1/2 120 min), but also sustained inhibitory potency (IC50 = 4.2 nM) and selectivity over CYP11B1 (SF = 422), CYP17, CYP19, and a panel of hepatic CYP enzymes.
I hope this article can help some friends in scientific research. I am very proud of our efforts over the past few months and hope to 1532-97-4, help many people in the next few years.Product Details of 1532-97-4
Reference：
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem